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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌto 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of Norway is 5,282,223 (World Bank, 2018a) and a birth rate estimated at 
11.2 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Norway has a reported population density of 14.46 people per square kilometre in 2017 and 
this has risen from 9.88 people per square kilometre in 1961 (World Bank, 2018c). Infant 
mortality in 2017 is estimated at 2.1 deaths/1,000 live births in total (World Bank, 2018d). 
The average life expectancy in Norway is estimated at 82.5 years (World Bank, 2018e), with 
a death rate of 7.8 deaths/1,000 population in 2016 (World Bank, 2018f). Norway has a gross 
national income per capita (PPP int. $, 2013) of $66,000 (WHO, 2016). The estimated total 
expenditure on health per capita in 2014 was $6,347 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 9.7% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Norway between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)  
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4 Vision Screening Commissioning and Guidance 
In Norway, vision screening is organised regionally by the local municipalities, of which there 
are 420. The responsibility of primary health care, of which vision screening is included, is the 
ƌĞƐƉŽŶƐŝďŝůŝƚǇŽĨƚŚĞŵƵŶŝĐŝƉĂůŝƚŝĞƐ ?ǁŝƚŚEŽƌǁĂǇ ?ƐMinistry of Health playing an indirect role 
through legislation and funding mechanisms. All municipalities provide and fund vision 
screening, which is embedded into a general preventative child healthcare screening system. 
Vision screening has been implemented since the 1970s. However, the first written 
Norwegian guidelines for vision screening in children are from 1998. The content of the vision 
screening programme is decided upon by the Norwegian Directorate of Health. In 2006, the 
guidelines were revised; the revised guidelines maintained the inclusion of visual acuity 
testing at 4 years of age, but now introduced a recommendation as to which visual acuity test 
should be performed.  
There are national general health screening guidelines for vision screening and the 
programme is revised every 5 to 10 years. A committee appointed by the National Health 
Authorities decides upon the revisions. The committee responsible for the last guidelines 
comprised of: 
x ophthalmologists 
x 1 orthoptist 
x 1 optometrist 
x 1 special education person (in visual problems) 
x 1 special nurse 
x 1 GP 
x 1 paediatric neurologist 
x 1 senior consultant from the health care ministry 
There are no methods for quality monitoring imposed by the government and there has been 
very little research carried out concerning the vision screening programme in Norway.  
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5 Screening programme  
The target conditions screened for by vision screening are retinopathy of prematurity (ROP), 
congenital eye disorders and reduced visual acuity. The health care professionals delivering 
vision screening, venue for screening and tests used vary depending on the age of the child. 
Specific details of the screening offered within each age group are described more fully in 
sections 5.1 to 5.4 below.    
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in a neonatal 
intensive care unit of a hospital. The tests conducted in preterm babies less than 32 weeks 
gestational age (GA) include ROP screening until full normal vascularisation of the retina. 
Preterm babies aged above 32 gestational weeks are screened in the same manner as full 
term babies as described in section 5.2.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies aged up to 3 months are screened by a paediatrician, GP, or a specialist 
nurse in a child healthcare centre. The tests conducted at this aged include eye inspection, 
fixation and red reflex testing (paediatrician). Red reflex and a general eye exam is tested at 
birth and 6 weeks of age. Babies are referred as soon as there are signs of abnormality. There 
is no defined policy for referral or observation when tests are inconclusive, this is at the 
discretion of the clinician. The red reflex examination is conducted at discharge and is 
performed by a paediatrician (or paediatrician-in-training). The further screening at the child 
healthcare centre is usually not performed by a paediatrician, but by GPs (the "general eye 
examination"). The "general eye examination" from birth to 3 months is defined in the 
national guidelines, and should include: 
x family history of any eye problems 
x problems concerning pregnancy or delivery 
x examination of red reflex 
x examination for any congenital anomaly 
x examination for abnormal eye movements 
x examination of visual behaviour/fixation pattern and following 
x ask for any worry or concern from the parents 
5.3 Vision screening - 3 months to 36 months 
Infants aged 3 to 36 months are screened by a specialist nurse or a GP at a mother and child 
healthcare centre. Testing is conducted four times during this period: at 3 months, 6 months, 
1 year and 2 years of age. The tests conducted include eye inspection, fixation, red reflex 
testing, Hirschberg test and pupillary reflexes. There is no defined policy for referral or 
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observation when tests are inconclusive; this is left to the discretion of the clinician. Due to 
low sensitivity and specificity, corneal light reflex and cover test has been omitted as a 
screening examination in the guidelines from 2006. Referral to an ophthalmologist in the 
period 3-36 months is based on a total judgement of both findings and worry from the parents 
and/or the specialist nurse. Manifest strabismus is also a reason for referral. 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years of age are screened once, between 4 and 5 years of 
age, by a specialist nurse at a mother and child healthcare centre. The tests conducted at this 
age include eye inspection, red reflex testing and a visual acuity measurement. Visual acuity 
is measured for the first time at 4-5 years of age, however, there are no recommendations as 
to which chart to use. In Norway, the Østerberg's chart has been the most commonly used 
test since the 1970s. To pass the visual acuity test, the child needed to see at least 3 objects 
on line 4/6 (or 0.67 decimal, 0.2 logMAR) in each eye. If the child failed, he/she were required 
to repeat the screening test after 1-2 months. If they failed again, he/she would be referred 
to an ophthalmologist. The LH chart (logMAR principle, uncrowded) is now the recommended 
chart. The indication for referral is now a visual acuity of less than 3 correct symbols (out of 
5) on line 3/4.8 (0.63) in one or both eyes and is not repeated at any other age. Referral is 
determined by less than 3 correct answers out of 5 symbols on the line 3/4.8 (Snellen 6/9.5 
or 0.225 logMAR) on charts measured to be used at 3 metres. A new investigation is 
conducted within 1-2 months if the child failed; otherwise, referral is necessary through 
indications based on general exam and medical history. 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist GP Specialist nurse  
Preterm babies  × 9 × × 
0 to 3 months  9 × 9 9 
3 to 36 months  × × 9 9 
3 to 7 years  × × × 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Red reflex 
testing 
Eye 
inspection 
Retinal 
examination 
Fixation Hirschberg Pupillary 
reflexes 
Visual acuity 
measurement 
General eye 
exam 
Preterm 
babies  
9 
>32 weeks 
GA 
9 
>32 weeks 
GA  
9 
<32 weeks GA 
 
9 
>32 weeks 
GA  
× × × 
9 
>32 weeks 
GA  
0 to 3 
months  
9 9 × 9 × × × 9 
3 to 36 
months  
9 9 × 9 9 9 × × 
3 to 7 years  9 9 × × × × 9 × 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Child healthcare centre 
Preterm babies  9 × 
0 to 3 months  × 9 
3 to 36 months  × 9 
3 to 7 years  × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated screening is conducted in Norway.  
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7 Provision for Visually Impaired  
The Norwegian school system is based on full integration and therefore there are no schools 
for blind or severely visually impaired children. Special education professionals monitor 
visually impaired children attending regular primary school. This is done through two special 
educational centres ("resource centres") that the municipal special educational teachers may 
refer children to or get special support from in difficult cases. The support and devices are 
financed by the government and include data equipment, low vision devices (e.g. cameras) 
and mobility training. 
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
No data available.  
8.2 Coverage 
All children are invited for vision screening as part of general screening in children. Invitations 
are sent out by letter as part of the official health system and all children are covered. 
Attendance is estimated at 97-98%. 
8.3 Screening evaluation 
The sensitivity of vision screening is estimated at 95%. The specificity of vision screening is 
estimated at 95%. These are rough estimates; unfortunately there is no research data 
available.  
8.4 Treatment success 
It is estimated that there are 1,500 operations per year for strabismus and approximately 2 
to 5% of preschool children are treated. This is based on national data in 2003, which showed 
that there were 1200 operations that year. No further data available. Ophthalmologists are 
professionals that prescribe glasses for children under the age of 7 years. Optometrists (since 
2000) are also allowed to prescribe glasses for children under 7 years of age, however, they 
are not permitted to use diagnostic eye drops on children under 5 years of age. Other 
treatment options include patching, atropine and cataract surgery where appropriate. All 
eligible children are offered treatment.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs per year for specialist nurses in mother and child healthcare centres (about 
600 centres across Norway) is 450,000 NOK (approximately 47,000 Euros, November 2018). 
A normal work shift is detailed as 7.5 hours per day. Vision screening is the main focus in this 
examination, but other factors are investigated, such as an evaluation of language, motor 
function, and physical activity. The 4 year old vision screening is stated as taking 
approximately 1 hour to complete.  
9.2 Cost of treatment for amblyopia 
No data available.  
9.3 Cost of Treatment for strabismus  
 No data available. 
9.4 Cost of treatment for cataract 
No data available.  
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